Acetylcysteine Injection
Product Images NDC 0574-0805

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acetylcysteine (NDC 0574-0805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure 1)

This is a visual aid for medical professionals to evaluate the likelihood of hepatotoxicity occurring based on the concentration of acetaminophen in plasma or serum, measured in ug/mL. There are two lines on the graph; if concentration values fall above the solid line, the likelihood of hepatoxicity is high, and if they fall on or above the broken line, the patient should continue acetylcysteine. The x-axis shows the hours post-ingestion and the y-axis shows the concentration values.*

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

Image 02

This text is a template for inserting the serial number, lot number, and expiration date of a product.*

FDA Label Image

Image 03

This is a description of Acetylcysteine Injection, available in sterile vials from Perrigo. Each vial contains 6g/30mL (200mg/ml) of the solution, which must be further diluted before intravenous use. The suggested dosage is not provided in the text. The rest of the text consists of unintelligible characters.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.